DPI Research

The United States insulin pen market size was valued at USD 4.2 billion in 2024 and is projected to hit around USD 8.1 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025 to 2033.

The U.S. Self-Monitoring Blood Glucose Devices market size was accounted for USD 4,045 million in 2023 and it is expected to reach around USD 7,138 million by 2032 poised to grow at a noteworthy CAGR of 6.5% during the forecast period

Explore the global diabetes insulin delivery pen market, valued at USD 17.7 billion in 2023 and projected to grow to USD 28.7 billion by 2032.

This growth is expected to continue, with projections indicating that the market could reach around US$ 9.66 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 8% from 2025 – 2033.

The United States Continuous Glucose Monitoring (CGM) market size was valued at USD 3.7 billion in 2024 and is projected to hit around USD 8.4 billion by 2033, growing at a CAGR of 9.5% during the forecast period 2025 to 2033.

The United States proton therapy market size was valued at USD 1 billion in 2024 and is projected to hit around USD 2.5 billion by 2033, growing at a CAGR of 12% during the forecast period 2025 to 2033.

China neuro-interventional device market size was valued at USD 2.7 billion in 2024 and is projected to hit around USD 10.2 billion by 2032, growing at a CAGR of 18% during the forecast period 2025 to 2032.

China neuro-interventional device market size was valued at USD 2.7 billion in 2024 and is projected to hit around USD 10.2 billion by 2032, growing at a CAGR of 18% during the forecast period 2

The United States insulin pen market is anticipated to reach around US$ 7.5 billion by 2033, witnessing an impressive double-digit growth rate in the forecast period 2025–2033.

Founded in 2016, DPI Research has quickly established itself as a pioneering entity in the realms of market research and strategic consulting. In a relatively short span of time, the company has made a significant